الفهرسة نشطة
للباحثين للناشرين تسجيل الدخول إنشاء حساب
الرئيسية المؤلفون Saad Alobid
SA

Saad Alobid

h-4 H-Index
26 Citations
5 Papers

Published Papers

5 indexed
1
Novel ibuprofen prodrug: A possible promising agent for the management of complications of Alzheimer’s disease
Saudi Pharmaceutical Journal Q1 2024 10.1016/j.jsps.2023.101888
8 citations 391
2
Protective effects of vanillic acid on letrozole-induced polycystic ovarian syndrome: A comprehensive study in female wistar rats
Saudi Pharmaceutical Journal Q1 2024 10.1016/j.jsps.2024.101953
7 citations 394
3
Targeting the PI3K/AKT/mTOR signaling pathway in prostate cancer: Molecular dysregulation, therapeutic advances, and future directions
Saudi Pharmaceutical Journal Q1 2026 10.1007/s44446-025-00056-w
6 citations 384
4
3D QSAR study on substituted 1, 2, 4 triazole derivatives as anticancer agents by kNN MFA approach
Saudi Pharmaceutical Journal Q1 2023 10.1016/j.jsps.2023.101836
5 citations 389
5
Discovery of a novel VEGFR2 inhibitor using integrated structure-based docking study and functional validation: potential applications in targeted cancer therapy
Saudi Pharmaceutical Journal Q1 2026 10.1007/s44446-026-00072-4
0 citations 387

Publication Activity

Journals Published In

Saudi Pharmaceutical Journal
🇸🇦 Q1 AMS 100
Saudi Pharmaceutical Journal
🇸🇦 Q1 AMS 100